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a  b  s  t  r a  c t
Levodopa  is  a drug  that  is  commonly  used  to  treat movement  disorders associated  with  Parkinson’s
disease.  Its dosage  requires  careful  monitoring,  since the required amount changes  over time,  and  excess
dosage  can lead to muscle spasms  known as levodopa-induced  dyskinesia.  In this  work, we investigate
the  potential  for  using epiNet, a novel artificial  gene regulatory network,  as a classifier for  monitoring
accelerometry  time  series  data  collected  from  patients  undergoing levodopa  therapy. We  also  consider
how  dynamical analysis  of epiNet  classifiers and  their transitions  between different states  can highlight
clinically useful information which  is  not available through  more conventional  data  mining techniques.
The results show  that epiNet  is  capable of  discriminating  between  different movement patterns  which
are  indicative of either  insufficient  or  excessive  levodopa.
© 2016  The Author(s).  Published by  Elsevier  Ireland Ltd.  This  is an open  access article under  the  CC  BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Since the beginnings of computer science, there have been
many successful attempts at capturing biological models within
a computational framework. This field, known as bio-inspired
computation, has given rise to  algorithms which have been shown
to out-perform humans on real world tasks, for instance in object
recognition (He et al., 2015). Indeed, many of the computational
algorithms that are now state of the art are built upon bio-inspired
principles (Oquab et al., 2014; Hinton et al., 2012; Yang et al.,
2013; Zhou et al., 2011). The design of bio-inspired algorithms
falls on a spectrum. At one end of this spectrum are attempts to
capture as much detail from the biological system as possible,
to best promote the possibility of emergent behaviour. At  the
other are intentionally minimalist approaches, using pared-back
models that capture only an abstract representation of the bio-
logical system. Each of these approaches has advantages, but
often the simpler models are  functionally complex and capable of
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capturing real-world biological dynamics (Bull, 2013; Wang et al.,
2012).
In  this work we use a novel bio-inspired architecture, termed
epiNet, which is modelled upon the interactions between genetic
and epigenetic processes within biological cells (Turner et al.,
2015). Computational modelling of genetic processes, in  the form of
artificial gene regulatory networks, is nothing new (Lones, 2016).
However, the inclusion of epigenetic elements allows for a con-
nectionist architecture with a  dynamical topological morphology
– that is, the ability for a  computational network to  autonomously
partition itself and select partitions based upon environmental or
internal state. This serves two primary advantages. First, it sup-
ports task specialisation, where a partition assigned to a specific
environmental or internal context is  only used in  that scenario. Sec-
ondly, with minimal analysis it provides a method of characterising
a network’s behaviour from the ground up, by mapping the func-
tionality of the individual partitions and building up an image of the
system’s transitions between these partitions. This helps automate
the process of model validation. Because of this, we propose that
the properties of epiNet lend themselves well to  the classification
and analysis of real world time series data, where the underlying
generative model is often poorly understood.
We describe the application of epiNet to  the particular problem
of understanding and classifying the movements associated with
the neurodegenerative disorder Parkinson’s disease when a patient
is undergoing treatment with the dopamine replacement drug
http://dx.doi.org/10.1016/j.biosystems.2016.05.005
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DNA
Histone Octamer
Accessible DNA
Fig. 1. DNA being wound around histone octamers over 1.67 turns, forming a chromatin fiber.
levodopa. Incorrect dosage of levodopa can have severe manifesta-
tions, notably the involuntary and violent muscle spasms known as
levodopa-induced dyskinesia (LID). Correct dosage involves finding
a balancing point between the removal of Parkinsonian symp-
toms and the onset of side-effects, providing a  challenge to both
patients and clinicians alike. In this work, we demonstrate the
potential of epiNet by  analysing the topological changes and transi-
tions between dynamical states within the model when classifying
movement data collected during levodopa therapy. We  show that it
is possible to provide clinically relevant information about LID, the
underlying data and the processes underpinning why at any given
point epiNet has made a  certain decision.
2.  Background
2.1. Epigenetics
Epigenetics refers to  mechanisms which result in changes in
gene expression without altering the underlying DNA (Bird, 2007;
Turner, 2001). In Fig. 1, a  general eukaryotic arrangement of DNA is
illustrated. Within the cell nucleus, DNA is wrapped around a his-
tone octamer over 1.67 turns. This combination of DNA and histones
is  referred to as chromatin, one of the major epigenetic structures.
Chromatin has two prominent biological roles: compressing the
size of a DNA strand, and controlling physical access to the DNA. The
dynamically varying structure of chromatin allows DNA to  move
relative to it, allowing the cellular machinery (e.g. polymerase, tran-
scription factors) to access it. Controlling this movement means
controlling which genes are  actively being transcribed at any given
moment. This idea is central to the model used within this paper,
where there exists a  ‘bank’ of genes (the genome) which is inac-
tive by default. Then, chromatin reorganises itself relative to the
DNA in order to change which genes are accessible to the cellular
machinery at any given time.
Additionally, there are other epigenetic marks. One of the most
pervasive is DNA methylation, where a  methyl group is added to
either the cytosine and adenine nucleotides within DNA. In a simi-
lar vein to chromatin modifications, methylations typically prevent
transcription by physically inhibiting the cellular machinery’s abil-
ity to straddle the DNA, preventing processes such as transcription
(Bird, 2007; Turner, 2001). There are also other epigenetic mecha-
nisms, such as micro RNAs, prions and SRNAs.
2.2. Epigenetic networks
The model used in  this work (previously described in Turner
et al. (2015)), builds upon a  range of previous work from more stat-
ically derived genetic and epigenetic functionality (representing
genetic networks and static epigenetic marks such as DNA methyl-
ation) (Lones et al., 2013; Turner et al., 2014; Reil, 1999; Bull, 2014)
to  more dynamic models which take inspiration from chromatin
modifications (Turner et al., 2013, 2015, 2016). Indeed, the low-
level element of epiNet, the artificial gene model, is derived from
(Lones et al., 2010), and remains unchanged. This artificial gene is a
computational element that takes inputs and processes them using
a  function, producing a single transformed output. In this paper, we
use a  sigmoid function, meaning that these low-level elements are
similar to perceptrons in artificial neural networks. This function
can be  parameterised during evolution, allowing the gradient of  the
function and offset to change for each individual gene, allowing for
functions ranging from the typical sigmoid to an approximate step
function (Fig. 2). Many of these genes are linked together to  form
an artificial gene regulatory network, in  which certain genes are
mapped to external inputs and outputs (Lones et al., 2010).
We have  explored several approaches to building epigenetic
structures into, or on top of, existing artificial gene regulatory
networks (Turner et al., 2013, 2014, 2015). In these models, genes
are generally always active unless made inactive by an epigenetic
analogue. Additionally, the epigenetic analogues are static and fixed
in  place and control a  small part of the network. With epiNet, by
comparison, genes are inactive until turned on by an epigenetic
analogue. The epigenetic analogues are then regulated by genes,
causing them to move around the genome, switching on and off
different parts of the network over the course of time.
The main structure in this model is  a  genetic structure, consist-
ing  of a number of genes (30–100) which exist on a  1-dimensional
linear scale (Fig. 3) between [0,1]. These genes are static and are not
directly executed. Execution of the genes occurs when genes are
copied from the genetic structure to  the protein network. The pro-
tein network functions in  a similar way to the networks in  (Lones
et al., 2010), where it is the structure which directly interacts with
an external environment (task) and is  executable. However, which
Fig. 2. The changes in the output of the sigmoid function according to different slope
parameters, which are optimised for each gene within the  network. With a  slope of
1,  the output can  be seen to  be a sigmoid with a shallow gradient. With a slope of
20, the sigmoid gradient is steep enough to approximate a step function.
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Fig. 3. The components of epiNet. Genes that are covered by an epigenetic ana-
logue  become expressed, forming a  structure akin to  a protein network. The protein
network then takes inputs from a task and is executed to produce output(s). The
epigenetic analogue is regulated by the protein network; following execution, it
reads expression levels in the protein network and passes them through a sigmoid
function. The result then becomes the next position of the epigenetic analogue.
genes are copied from the genetic structure to the protein network
is controlled by the epigenetic molecule.
The epigenetic molecule(s) within epiNet straddles the genome,
existing in the same 1-dimensional space. Each epigenetic molecule
has a position in this 1-dimensional space and a  size  (Fig. 1). The size
is fixed, but the position is a  variable. At  each time  step, whichever
genes exist within the space occupied by the epigenetic molecule
are then copied from the genome to the protein network. At each
time step, the epigenetic molecule takes selected inputs from the
protein network, and processes them using a  sigmoid function
(identical to the genes) and this output then becomes the epige-
netic molecules new position. Hence, the position of the epigenetic
molecule on the genome is  the product of the structure and state
of the protein network. Upon initialisation, epiNet will contain 3
epigenetic molecules, however multiple epigenetic molecules can
be incorporated to the network throughout the optimisation pro-
cess. After each execution the protein networks expression values
are mapped back to the genome. This serves to give the protein net-
work and genome a  relative memory of its previous state. Following
execution, all the proteins within the protein network are removed
and will become repopulated according to  the position of the epi-
genetic molecule on the next step. An external task can interface
with epiNet by  modifying protein expression within the protein
network. In this work, epiNets are initialised with 40 genes and 3
epigenetic molecules; however, new components may  be gener-
ated and removed allowing the modification of their parameters
throughout the course of evolution.
2.3. Parkinson’s disease
Parkinson’s disease (PD) is a chronic neurodegenerative disor-
der which is characterised by  progressively impaired motor control
due to loss of dopaminergic neurons in the brain (Nalls et al.,
2014). Although the underlying cause of Parkinson’s is unknown,
it has been linked to various genetic and environmental factors
(Impellizzeri et al., 2015; Lolekha et al., 2010).
Currently approximately 1% of people over 60 suffer from PD;
however, with a  globally ageing population, it is  estimated that
this will increase significantly (Lill et al., 2012). Clinical diagnostic
accuracy for PD is relatively low and research studies have shown
that approximately 8–25% of cases are misdiagnosed (Schrag et al.,
2002; Hughes et al., 1992). This is  in part  due to the overlap of
symptoms associated with a  range of other diseases including pro-
gressive supranuclear palsy, multiple system atrophy, corticobasal
syndrome, and vascular Parkinsonism. One of the most successful
treatments for the motor symptoms of Parkinson’s is  a  dopamine-
replacement drug, levodopa. When using levodopa, there is an
issue of fine tuning a  patient’s medication to  their exact require-
ments: insufficient dosage results in ineffective treatment, excess
dosage can lead to levodopa-induced dyskinesia (LID), which may
manifest as violent muscle spasms. Clinicians fine-tune a  patient’s
medication regimens based on their own  ratings of the patient’s
symptoms and on patient-rated treatment response. These metrics
may  be insensitive to  small but  important effects and additionally,
these metrics correlate only weakly with each other (Fahn et al.,
2004). Moreover, it is  often difficult to  separate the symptoms of
Parkinson’s from LID. Hence, a  more personalised computational
approach is  desirable, where dosage guidance can be  inferred from
models trained using real patient data.
3. Methodology
The objectives of this work are:
• To understand the properties of epiNet as a  predictive modelling
tool for the analysis of levodopa-induced dyskinesia
• To understand how the analysis of epiNet’s topological mor-
phology when classifying the data can provide useful clinically
relevant information about levodopa-induced dyskinesia
To achieve these objectives, we applied epiNet to the classifica-
tion of real world medical data derived from accelerometers worn
by Parkinson’s patients undergoing a  levodopa based medication
regime.
3.1. Clinical study data
The data was acquired from 25 patients who had confirmed
symptomatic Parkinson’s disease and were being treated with lev-
odopa therapy. The patients wore small lightweight sensing devices
with integrated accelerometers and gyroscopes to  monitor their
movements at a sample rate of 100 Hz. These devices each stored 6
channels of information, corresponding to acceleration in  the three
translational and three rotational axes. The patients were uncon-
strained yet asked to complete various movement tests throughout
a  2 h window at non-specific intervals. Whilst doing this, the
patients were recorded using an infrared video camera. Trained
clinicians then used these recordings to  grade the data, using the
Unified Dyskinesia Rating Scale (UDysRS) to mark up  periods of  LID.
The data was  cross-correlated between clinicians to ensure accu-
racy over the grading of the patients. The patients were rated on
a  scale of 0–4, where 0 corresponds to the patient displaying no
signs of dyskinesia, and 4 corresponds to severe dyskinesia. Table 1
summarises the number of instances of each grade of dyskinesia
within the data set.
3.2. Evolutionary algorithms
Evolutionary algorithms (EAs) are population-based meta-
heuristics which carry out optimisation procedures motivated by
biological evolution. Evolution is  the process of adapting an indi-
vidual or population to  environmental dynamics over successive
Table 1
Instances of each grade of dyskinesia.
Dyskinesia
UDysRS Count
0 4264
1  2004
2 2151
3  829
4 424
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generations via the stochastic breeding of population members.
Evolutionary algorithms model this principle by using the data of a
system or model as a genome, and by  crossing over and mutating
solutions within a  population according to an objective measure
of their ability to solve a problem (known as their fitness).  Over
successive generations, the individuals’ fitness will improve as the
population learns to  solve a  particular task.
EAs are relatively flexible in  how they represent and evaluate
solutions. Their appropriateness for optimising epiNets is  also sug-
gested by the role of biological evolution in  designing biological
genetic regulatory systems. For these reasons, we used them to
optimise both the architecture and parameters of the epiNet model
in order to solve the problem of predicting the degree of dyskinesia
in segments of accelerometry time series data. We  used the multi-
objective evolutionary algorithm NSGA-II (Deb et al., 2002) with a
population size of 400 and an optimisation period of 250 genera-
tions. We  used tournament selection of size 4. Point mutation was
used for all components of the genome and epigenome with a  prob-
ability of 0.05. The crossover operator exchanged 30% of the data
between individuals, and the crossover rate is 0.5. These param-
eters were selected as previous exploratory experimentation has
shown that these allow for the evolution of complex behaviours
which were not able to be learned by  other algorithms within iden-
tical time frames (Turner, 2013; Turner et al., 2015).
We  use a multi-objective fitness function in this work. The first
objective is to correctly classify each time step within a data seg-
ment, with one point awarded for each correct classification. The
second aggregates the points awarded for a  data segment; if over
50% of the time points are  correct, that data segment is  considered
to be correctly classified and a point is awarded. This allows the
system to handle variable-sized data segments (204–16,001 time
steps) without biasing search towards classifiers that perform well
on only the shorter or  longer samples, which tends to happen when
only one of these objectives is used.
3.3. Data handling
The complete data set contained 9672 labelled sequences. To
make the optimisation process computationally tractable, we uni-
formly sub-sampled (without replacement) 1000 instances for use
as a training set. The remaining samples were used for testing,
allowing a fairly robust estimate of a classifier’s generality.
The data was split into 2 classes of dyskinesia severity: high and
low. High indicates an LID rating of either 2, 3 or 4. These correspond
to clinically significant levels of dyskinesia that require a change in
levadopa dosage. Low indicates an LID rating of 0 or 1, i.e. no, or
very mild, dyskinesia. The training data was split accordingly; the
low class comprising 500 data segments, with 250 rated 0 and 250
rated 1, the high class comprising 500 data segments with 166 rated
2, 167 rated 3, and 167 rated 4.
Each data segment comprises 6 times series, corresponding to
changes of acceleration over time in  the three translational and
rotational axes. At  each time step, this multivariate data is  fed into
an epiNet classifier as a  group of 6 values, each copied into the
activation levels of input genes. After the epiNet has processed the
input, a single output is read from the expression level of an out-
put gene. An output value below 0.5 is  interpreted as indicating
low dyskinesia; a value equal to or greater than 0.5 indicates high
dyskinesia.
4. Results
We  carried out 20 independent runs, during which each epiNet
classifier was evaluated on its ability to correctly predict the labels
of each time step and each data segment within the training set.
Fig. 4.  Objective values for epiNet classifiers from the  final generations of 20 evo-
lutionary runs, showing performance on both the training and test sets. The x-axis
shows the proportion of time steps which were correctly classified and the y-axis
shows the proportion of data segments which were correctly classified (i.e. where
at  least 50% of the time steps within each segment were classified correctly).
Following these 20 runs, all the final generation classifiers were
re-evaluated on the test set. Fig. 4 shows the performance of these
controllers on both the training and test sets, with each point show-
ing  the per-step and per-segment accuracy of a single controller.
On the training set, classifiers were found with accuracies of ∼80%.
When re-evaluated on the test set, accuracies dropped to around
∼70%; however, most showed an ability to  generalise.
Fig.  5 summarises the distributions for both objectives. It  is
notable that test set accuracies were significantly higher for whole
data segments (more important from a  clinical viewpoint) rather
Fig. 5. Distributions of objectives values amongst the final generation epiNet clas-
sifiers,  showing per-step and per-segment classification accuracies for both the
training  and test sets. This is  a transformation of the data shown in Fig. 4.
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than individual time steps. This is unsurprising, given the larger
amount of historical time series data present in an entire data seg-
ment, and the relative stochasticity of movements at a  single time
step. However, it is also evident from Fig. 4 that  the majority of the
classifiers are fairly balanced in their responses at the per-step and
per-segment level, with most clustered along the diagonal.
4.1. Analysis of network dynamics
The results show that trained instances of the epiNet model
are capable of classifying movements associated with levodopa
therapy. We  next carried out post-hoc analysis of the dynamical
behaviour of the epiNet classifiers, in  order to gain some insight
into how they achieve this.
Figs. 6  and 7 show the dynamical response of a  single evolved
epiNet classifier whilst processing two different acceleration time
series data segments. First of all, it is evident that the dynamics of
the network are adaptive, with the activation levels of the genes
and the positions of the epigenetic analogues undergoing signif-
icant changes during the course of classification. This change in
dynamics is caused by the autonomous topological changes of the
network as a result of changing dynamics in the environmental
input data. Analysis of a sample of the evolved classifiers sug-
gests that this behaviour is typical, with <5% of the instances not
undergoing topological change whilst processing the input data,
and these topologically-invariant solutions having generally lower
fitness values. This suggests that  topological change is  a  useful
mechanism, and it seems likely that topological changes are driven
by, and hence are a  signal of, dynamical changes in the patient’s
movements.
For the network analysed in  Figs. 6 and 7, some genes are almost
always active (approximately 3–5), some genes are never active,
and others are intermittently active. Additionally, the size of the
expressed network varies significantly over time; sometimes no
genes are active, sometimes upwards of 15 are active. It  can also
be noticed (particularly in Fig. 7)  that some changes in the activity
of the genes do not lead to changes in the overall dynamics of the
network. For example, at time steps 220–800, gene 31 is constantly
being activated and deactivated, yet this causes no discernible dif-
ference in the network’s output.
The evolutionary algorithm was given the freedom to evolve
the architecture of the epiNets within bounds. The initial param-
eters for the network were 40 genes and 3 epigenetic molecules
and most networks maintained a  similar architecture throughout
optimisation. The number of genes varied little, with the largest
solutions containing 52 genes, the smallest containing 30. There
appeared to be no discernible difference between the performance
of networks based on the number of genes alone. Most functional
solutions contained 3 epigenetic molecules. However, a  significant
number contained only 2,  but these otherwise functioned similarly
to the networks containing 3: suggesting that useful behaviour can
be achieved with less molecules, but with some impairment to evol-
vability. Networks which contained 1 or 4 epigenetic molecules had
poor functionality, with neither of them resulting is a solution in
the top 20% of the population. A possibility, as seen is  previous work
is that too many epigenetic molecules leads to a greater likelihood
of interference between regulatory regions.
4.2. Knowledge extraction
The data used to train the networks contains 6 input channels
and a single output. EpiNet allows these inputs to  be mapped onto
genes multiple times (i.e. one input gets mapped onto multiple
genes); it also allows particular inputs to be ignored by the net-
work (Fig. 8). To understand the way in which epiNet classifiers
use the inputs, we analysed the best evolved solutions.
Fig. 6. An  epiNet’s dynamics at each time step when classifying a  single data seg-
ment, showing the activity of each gene, the  positions of the epigenetic molecules
and the output from the network. This network classified 53% of the time steps
correctly, leading to  a  correct classification for the segment. The network shows
somewhat disordered dynamics and appears not to remain in a  dynamical regime
for  more than around 200 time steps. This is  the same network as in Fig. 7.
A pervasive trend was for 3 of the 6 inputs to be used signif-
icantly more than the others, although none of the high fitness
networks used a permanently static mapping. Inputs 2,  3  and 6
were a common choice; however, 4 and 5 were also used widely
in  other networks. It  was also common for input 1 (acceleration in
the x-plane) to  be completely ignored by the networks. In many
solutions, single inputs were mapped onto multiple genes (mostly
2, sometimes 3 or 4), which were then excited in  tandem. Hence,
a particular input could drive multiple regulatory circuits. This can
be interpreted as an indication of the relative importance of the
input variable. However, over the course of execution, not all inputs
remained in  use. This can be seen as a  context sensitive switch, with
input signals driving topological change that causes the network to
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Fig. 7.  An epiNet’s dynamics at each time step when classifying a single data seg-
ment, showing the activity of each gene, the positions of the epigenetic molecules
and  the output from the  network. This  network classified 91% of the time steps cor-
rectly, leading to a correct classification for the segment. After the first 200 steps a
stable regime is maintained with only minor changes in the dynamics thereafter.
This  is the same network as in Fig. 6.
focus on movement in  particular axes. For instance, for over 75% of
the networks’ execution, half of the inputs are not used.
For further analysis, we  looked at creating a  minimum work-
ing example (MWE)  of an evolved solution, assuming that evolved
epiNets would be architecturally more complex than they needed
to be in order to  solve the problem. This was  done by itera-
tively removing a  gene from the network and then re-evaluating
it. If the performance worsened, the gene was replaced; if  not, it
was removed permanently. The epiNet architecture is  particularly
robust to deleterious mutations as its genes are not all intercon-
nected during execution, and it is therefore unlikely that all of the
dynamical regimes of the network would be  affected by a  single
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Fig. 8. A typical evolved mapping of the accelerometer inputs to  genes. Certain
inputs are mapped onto different genes which are close in proximity. These genes
are  often executed together. In addition, each solution tends to ignore one of the six
inputs permanently.
gene deletion. We found that removing genes had a  less damag-
ing  effect to  the networks’ performance then removing epigenetic
molecules, which almost always adversely affected performance.
The networks we considered initially started with 40 genes, and in
general could be reduced to  around 5  genes (Fig. 9). Although this
had no effect on functionality, the networks in this state were more
sensitive to perturbations; because of this increased sensitivity, it
is probable that they lacked the ability to move through the search
space in as timely a manner as the original networks, as small per-
turbations would be likely to  dramatically alter behaviour. Because
these networks were artificially created by removing genes, it is
difficult to fully assert what the networks structure would be if
they were evolved to be as small as possible. However, in  previous
work (Turner et al., 2015) it was shown that doing such, removed
the robustness of the networks during execution, but the networks
were still able to find solutions to complex tasks. Hence it is likely
that artificially altering network structure has different effects than
evolving the networks to do  so.
The functioning of an MWE  version of the network analysed in
Fig.  9 is depicted in  Fig. 10,  showing the activity of each gene over
a  transitional period. This network was capable of classifying both
time steps and data segments with over 69% accuracy. It can be seen
that genes 1 and 5 initially oscillate. Whilst in  this dynamical phase,
the network is  completely inactive for 50% of the time. Once the
transition occurs, genes 3 and 4 become permanently active. This
switching behaviour was common in the MWEs, and in  general the
networks appeared to have two  stable attractors corresponding to
movements in the high and low dyskinetic classes. The transition
between attractors was  also, in most cases, permanent, suggesting
that once a significant dyskinetic signal was  detected, the network
remained in the high dyskinesia state, increasing the likelihood of
classifying the whole segment as exhibiting dyskinesia. For  most
MWEs, it was  also evident that the transition between attractors
was governed by a single input. Although other inputs might be
mapped to  genes after this transition, the permanent change in
attractor meant that they were not being used.
This suggests that it is  possible to  train effective classifiers using
only a  single channel of the accelerometry data. This is  significant,
as it could considerably reduce the training time  of the networks. It
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Fig. 9. Mapping of the accelerometer inputs to  genes in the smallest network created
by  iteratively removing genes and re-evaluating. This network contained only 5
genes and 2 epigenetic molecules.
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Fig. 10. The activity of each gene in the minimum working example depicted in
Fig. 9.  Initially genes 1 and 5 are oscillating, where at one time step they are both
active, and at the next, neither are active. At these points the entire network is com-
pletely inactive. At time step ∼1475, the network changes and starts continuously
executing genes 3 and 4 after a  single execution of genes 2, 3  and 4. The transition
between gene activity shown is the only transition during the 3500 steps in this data
instance.
also  means that patients could be  fitted with simpler sensors that
consume less energy and are therefore less bulky. Furthermore, the
MWE  equivalents of the evolved classifiers are quite small. In  prin-
ciple, this means they could be implemented in a  relatively small
digital (or potentially analogue) circuit deployed within a  sensor
platform. This could provide a single-device solution to monitoring
dyskinesia in Parkinson’s patients.
4.3. Conclusion
In this paper we  have shown that epiNet is  able to  clas-
sify levodopa-induced dyskinesia within patients suffering from
Parkinson’s disease. We have also shown how analysis of an
epiNet’s structure can give us insight into both how and why clas-
sification decisions have been made. In particular we  showed that
post-processing of the networks could often reduce the number of
genes in the network from 40 to  around 5 without altering func-
tionality. This also showed that the networks could make decisions
based on a single accelerometer input, significantly increasing the
efficiency of execution. This opens up the opportunity for small,
wearable diagnostic tools to  be implemented using a  hardware
model of the MWEs.
The results are promising, however, there were specific caveats
associated with the work in  this paper. The first is  that the com-
bination of population based evolutionary algorithms and epiNet
meant that run times were relatively high. This limited the scope
of the networks ability to learn, but conversely, also allowed for a
comprehensive method of testing because a large amount of data
was not used in training. It would have also been beneficial to
allow for a larger population size and more generations to gather
a better understanding of epiNet’s potential. A further possibility
to improve this is to migrate the software to  a  GPU implementa-
tion as a significant part of the processing within the networks is
floating point arithmetic, hence, the performance increase should
be substantial. Within this work there has not been a direct focus
on objective performance, but a  focus on the underlying dynam-
ics of the networks when classifying high frequency movement
data. Because of the novel dynamical properties of the network,
we feel that direct comparison with other techniques with differ-
ing dynamical functionality would at present be of limited value
as variations in performance could be attributed to the parameters
of the respective techniques. The work in  this paper is to  be used
as an underpinning of future research in  which a robust analysis
of  epiNets performance will be carried out in  reference to other
models, such as those in Lones et al. (2014b).
Within this work we had to reclassify the data into either a high
or low levodopa-induced dyskinesia rating. In  addition, there was  a
class imbalance where there was an order of magnitude more data
available data sets with no levodopa-induced dyskinesia, compared
to  those who  had the most pronounced symptoms. Hence, it might
be  possible to look at a  class weighting which is dependent on clas-
sification outcomes (and how incorrect classifications may  effect
patients) and the relative performance of the networks. Indeed, it
may also be beneficial to  look at re-balancing the classes by omit-
ting certain classifications within the data (to only focus on the
most severe symptoms) as seen in Lones et al. (2014a).
Overall, the results in this paper have shown that epiNet has
significant potential as a  classification tool, and that the analysis
of the network structure and dynamics can provide clinically rel-
evant information about the decisions made by epiNet which are
important both for patient outcome and model validation.
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